Related Experiment Videos

[Progressive multifocal leukoencephalopathy. Contribution of nuclear magnetic resonance imaging]

D Strubel1, F Kuntzmann, G Kieffer

  • 1Service de Médecine-Interne Gériatrie, Hôpital de la Robertsau, Strasbourg.

La Revue De Medecine Interne
|March 1, 1990
PubMed

Insights

Progressive multifocal leukoencephalopathy (PML) is a rare brain infection affecting immunocompromised individuals. This case highlights diagnostic challenges and confirms PML in a patient with chemotherapy-resistant lymphoma.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Oncology

Background:

  • Progressive multifocal leukoencephalopathy (PML) is a demyelinating disease of the central nervous system.
  • PML is caused by the JC virus (a polyomavirus or papovavirus) and primarily affects immunocompromised patients.
  • Patients with hematologic malignancies, including lymphoma, are at increased risk.

Observation:

  • A 74-year-old woman with abdominal lymphoma, refractory to chemotherapy, presented with neurological symptoms.
  • Cerebral computed tomography (CT) and nuclear magnetic resonance (NMR) imaging suggested PML.
  • The diagnosis was definitively confirmed by postmortem pathological examination.

Findings:

  • The case illustrates the diagnostic utility of neuroimaging in identifying PML in immunocompromised patients.
  • Chemotherapy-resistant lymphoma was the underlying condition predisposing the patient to PML.
  • Postmortem examination provided definitive pathological confirmation of PML.

Implications:

  • Early and accurate diagnosis of PML is crucial for patient management, although treatment options are limited.
  • Understanding the contribution of various diagnostic modalities can improve PML detection in at-risk populations.
  • This case underscores the importance of considering opportunistic infections like PML in immunocompromised patients with neurological deficits.

Related Concept Videos